CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade LifeStance Health Group - LFST CFD

6.20
0.64%
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.07
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Lifestance Health Group Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 6.24
Open* 6.15
1-Year Change* 18.04%
Day's Range* 6.14 - 6.29
52 wk Range 4.63-9.59
Average Volume (10 days) 1.21M
Average Volume (3 months) 21.21M
Market Cap 2.56B
P/E Ratio -100.00K
Shares Outstanding 378.61M
Revenue 1.00B
EPS -0.52
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Feb 26, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 22, 2024 6.24 0.05 0.81% 6.19 6.34 6.13
Feb 21, 2024 6.27 -0.21 -3.24% 6.48 6.50 6.19
Feb 20, 2024 6.65 0.23 3.58% 6.42 6.65 6.39
Feb 16, 2024 6.59 0.10 1.54% 6.49 6.94 6.49
Feb 15, 2024 6.91 0.02 0.29% 6.89 6.99 6.77
Feb 14, 2024 6.89 0.31 4.71% 6.58 6.91 6.51
Feb 13, 2024 6.59 0.04 0.61% 6.55 6.77 6.46
Feb 12, 2024 6.97 0.51 7.89% 6.46 6.97 6.46
Feb 9, 2024 6.61 0.28 4.42% 6.33 6.61 6.33
Feb 8, 2024 6.46 0.57 9.68% 5.89 6.47 5.89
Feb 7, 2024 5.98 0.11 1.87% 5.87 6.05 5.84
Feb 6, 2024 5.98 0.37 6.60% 5.61 6.01 5.57
Feb 5, 2024 5.67 -0.16 -2.74% 5.83 5.92 5.62
Feb 2, 2024 5.97 0.68 12.85% 5.29 6.07 5.21
Feb 1, 2024 5.60 0.89 18.90% 4.71 5.76 4.67
Jan 31, 2024 5.96 0.01 0.17% 5.95 6.29 5.88
Jan 30, 2024 6.08 -0.38 -5.88% 6.46 6.50 5.91
Jan 29, 2024 6.56 0.23 3.63% 6.33 6.58 6.26
Jan 26, 2024 6.40 0.09 1.43% 6.31 6.61 6.31
Jan 25, 2024 6.44 -0.13 -1.98% 6.57 6.69 6.31

LifeStance Health Group Events

Time (UTC) Country Event
Wednesday, February 28, 2024

Time (UTC)

13:30

Country

US

Event

Q4 2023 Lifestance Health Group Inc Earnings Call
Q4 2023 Lifestance Health Group Inc Earnings Call

Forecast

-

Previous

-

Time (UTC)

13:30

Country

US

Event

Q4 2023 Lifestance Health Group Inc Earnings Release
Q4 2023 Lifestance Health Group Inc Earnings Release

Forecast

-

Previous

-
Monday, April 29, 2024

Time (UTC)

10:00

Country

US

Event

Q1 2024 Lifestance Health Group Inc Earnings Release
Q1 2024 Lifestance Health Group Inc Earnings Release

Forecast

-

Previous

-
Friday, May 31, 2024

Time (UTC)

17:00

Country

US

Event

Lifestance Health Group Inc Annual Shareholders Meeting
Lifestance Health Group Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019
Total revenue 859.542 667.511 377.217 212.518
Revenue 859.542 667.511 377.217 212.518
Total Operating Expense 1081.54 972.026 398.965 199.463
Selling/General/Admin. Expenses, Total 373.902 430.54 311.303 179.633
Depreciation / Amortization 69.198 54.136 31.045 6.095
Unusual Expense (Income) 15.913 21.347 37.184 2.186
Other Operating Expenses, Total 622.525 466.003 19.433 11.549
Operating Income -221.996 -304.515 -21.748 13.055
Interest Income (Expense), Net Non-Operating -8.828 -24.511 -22.132 -5.409
Other, Net -1.906 -4.079 -0.531 0.229
Net Income Before Taxes -232.73 -333.105 -44.411 7.875
Net Income After Taxes -215.564 -307.197 -38.07 5.669
Net Income Before Extra. Items -215.564 -307.197 -38.07 5.669
Net Income -215.564 -307.197 -38.07 5.669
Total Adjustments to Net Income 0 -36.75 -273.244 -64.573
Income Available to Common Excl. Extra. Items -215.564 -343.947 -311.314 -58.904
Income Available to Common Incl. Extra. Items -215.564 -343.947 -311.314 -58.904
Diluted Net Income -215.564 -343.947 -311.314 -58.904
Diluted Weighted Average Shares 355.278 327.523 373.649 373.649
Diluted EPS Excluding Extraordinary Items -0.60675 -1.05015 -0.83317 -0.15765
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -0.57335 -0.97291 -0.7687 -0.15343
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 259.578 252.589 229.36 217.56 209.527
Revenue 259.578 252.589 229.36 217.56 209.527
Total Operating Expense 307.994 286.768 275.587 256.609 270.018
Selling/General/Admin. Expenses, Total 101.557 84.334 89.237 80.382 102.708
Depreciation / Amortization 19.53 19.069 18.887 17.884 16.743
Unusual Expense (Income) 0.3 0.378 0.795 1.076 0.87
Other Operating Expenses, Total 186.607 182.987 166.668 157.267 149.697
Operating Income -48.416 -34.179 -46.227 -39.049 -60.491
Interest Income (Expense), Net Non-Operating -5.119 -5.092 -5.165 -4.189 -7.133
Other, Net 1.515 0.992 -2.324 1.032 -0.18
Net Income Before Taxes -52.02 -38.279 -53.716 -42.206 -67.804
Net Income After Taxes -45.478 -34.242 -46.656 -37.853 -68.727
Net Income Before Extra. Items -45.478 -34.242 -46.656 -37.853 -68.727
Net Income -45.478 -34.242 -46.656 -37.853 -68.727
Total Adjustments to Net Income 0 0 0
Income Available to Common Excl. Extra. Items -45.478 -34.242 -46.656 -37.853 -68.727
Income Available to Common Incl. Extra. Items -45.478 -34.242 -46.656 -37.853 -68.727
Diluted Net Income -45.478 -34.242 -46.656 -37.853 -68.727
Diluted Weighted Average Shares 363.161 360.902 358.941 357.52 353.729
Diluted EPS Excluding Extraordinary Items -0.12523 -0.09488 -0.12998 -0.10588 -0.19429
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.10751 -0.09222 -0.12564 -0.10257 -0.19269
  • Annual
  • Quarterly
2022 2021 2020 2019
Total Current Assets 233.223 266.52 76.28 27.425
Cash and Short Term Investments 108.621 148.029 18.829 3.481
Cash & Equivalents 108.621 148.029 18.829 3.481
Total Receivables, Net 101.508 94.695 46.934 19.13
Accounts Receivable - Trade, Net 100.868 76.078 43.706 18.633
Prepaid Expenses 12.097 19.454 10.517 4.814
Total Assets 2173.87 1927.11 1569.73 280.779
Property/Plant/Equipment, Total - Net 393.62 152.242 59.349 22.426
Property/Plant/Equipment, Total - Gross 436.503 171.768 63.781 26.717
Accumulated Depreciation, Total -42.883 -19.526 -4.432 -4.291
Goodwill, Net 1272.94 1204.54 1098.66 214.614
Intangibles, Net 263.294 300.355 332.796 14.951
Other Long Term Assets, Total 10.795 3.448 2.647 1.363
Total Current Liabilities 175.999 116.752 75.921 55.007
Accounts Payable 12.285 14.152 7.688 3.642
Accrued Expenses 132.817 76.055 46.98 23.545
Notes Payable/Short Term Debt 0 0 0 0
Other Current Liabilities, Total 28.552 25.222 17.515 27.82
Total Liabilities 655.148 382.081 536.895 144.221
Total Long Term Debt 225.079 157.416 362.534 79.314
Long Term Debt 225.079 157.416 362.534 79.314
Deferred Income Tax 38.701 54.281 81.226 0.863
Other Liabilities, Total 215.369 53.632 17.214 9.037
Total Equity 1518.72 1545.03 1032.84 136.558
Preferred Stock - Non Redeemable, Net 0 0 302.913
Common Stock 3.761 3.743 1044.51 0.003
Additional Paid-In Capital 2084.32 1898.36 1.452 0
Retained Earnings (Accumulated Deficit) -572.636 -357.072 -13.125 -166.358
Total Liabilities & Shareholders’ Equity 2173.87 1927.11 1569.73 280.779
Total Common Shares Outstanding 375.964 374.255 373.649 373.649
Current Port. of LT Debt/Capital Leases 2.345 1.323 3.738
Other Current Assets, Total 10.997 4.342
Other Equity, Total 3.274
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 264.25 237.881 212.509 233.223 252.587
Cash and Short Term Investments 42.605 79.605 68.294 108.621 90.336
Cash & Equivalents 42.605 79.605 68.294 108.621 90.336
Total Receivables, Net 149.716 121.796 118.382 100.868 113.284
Accounts Receivable - Trade, Net 149.716 121.796 118.382 100.868 113.284
Prepaid Expenses 71.929 36.48 25.833 23.734 48.967
Total Assets 2175.07 2170.92 2158.56 2173.87 1979.66
Property/Plant/Equipment, Total - Net 370.752 384.525 389.704 393.62 193.393
Property/Plant/Equipment, Total - Gross 434.822 442.872 440.437 436.503 232.82
Accumulated Depreciation, Total -64.07 -58.347 -50.733 -42.883 -39.427
Goodwill, Net 1293.43 1293.5 1293.61 1272.94 1249.79
Intangibles, Net 233.615 243.788 253.964 263.294 272.473
Other Long Term Assets, Total 13.023 11.221 8.772 10.795 11.416
Total Current Liabilities 240.874 180.854 181.141 175.999 112.272
Accounts Payable 10.4 8.044 7.709 12.285 7.947
Accrued Expenses 218.252 158.938 157.342 144.902 90.879
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 9.627 11.277 13.745 16.467 11.301
Total Liabilities 720.018 676.041 653.433 655.148 448.159
Total Long Term Debt 248.371 248.718 224.761 225.079 212.042
Long Term Debt 248.371 248.718 224.761 225.079 212.042
Deferred Income Tax 38.403 38.324 37.569 38.701 55.408
Other Liabilities, Total 192.37 208.145 209.962 215.369 68.437
Total Equity 1455.05 1494.88 1505.13 1518.72 1531.5
Common Stock 3.788 3.782 3.767 3.761 3.761
Additional Paid-In Capital 2162.77 2141.25 2108.18 2084.32 2050.54
Retained Earnings (Accumulated Deficit) -715.887 -654.304 -608.826 -572.636 -525.98
Total Liabilities & Shareholders’ Equity 2175.07 2170.92 2158.56 2173.87 1979.66
Total Common Shares Outstanding 378.607 378.005 376.537 375.964 376.042
Current Port. of LT Debt/Capital Leases 2.595 2.595 2.345 2.345 2.145
Preferred Stock - Non Redeemable, Net 0
Other Equity, Total 4.381 4.151 2.004 3.274 3.185
  • Annual
  • Quarterly
2022 2021 2020 2019
Net income/Starting Line -215.564 -307.197 -38.07 5.669
Cash From Operating Activities 52.789 9.42 -8.533 17.048
Cash From Operating Activities 69.198 54.136 31.045 6.095
Deferred Taxes -16.733 -26.945 -6.501 1.76
Non-Cash Items 232.826 287.286 5.746 0.532
Cash Taxes Paid 2.237 1.093 0.246 0.254
Cash Interest Paid 14.365 22.415 17.149 4.582
Changes in Working Capital -16.938 2.14 -0.753 2.992
Cash From Investing Activities -139.461 -194.076 -861.169 -73.375
Capital Expenditures -79.255 -94.492 -38.066 -14.314
Other Investing Cash Flow Items, Total -60.206 -99.584 -823.103 -59.061
Cash From Financing Activities 47.264 313.856 912.274 48.463
Financing Cash Flow Items -20.685 -11.18 600.867 -6.987
Issuance (Retirement) of Stock, Net 0 549.905 20 0
Issuance (Retirement) of Debt, Net 67.949 -224.869 291.407 55.45
Net Change in Cash -39.408 129.2 42.572 -7.864
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -34.242 -215.564 -168.908 -131.055 -62.328
Cash From Operating Activities -7.89 52.789 16.871 11.141 3.308
Cash From Operating Activities 19.069 69.198 50.311 32.427 15.684
Deferred Taxes -16.733
Non-Cash Items 33.536 232.826 156.548 122.107 60.584
Cash Interest Paid 5.059 14.365 9.518 4.927 3.091
Changes in Working Capital -26.253 -16.938 -21.08 -12.338 -10.632
Cash From Investing Activities -27.549 -139.461 -109.165 -88.893 -50.855
Capital Expenditures -7.729 -79.255 -68.871 -53.775 -27.91
Other Investing Cash Flow Items, Total -19.82 -60.206 -40.294 -35.118 -22.945
Cash From Financing Activities -4.888 47.264 34.601 26.409 13.508
Financing Cash Flow Items -4.302 -20.685 -20.034 -18.752 -6.161
Issuance (Retirement) of Stock, Net 0 0 0
Issuance (Retirement) of Debt, Net -0.586 67.949 54.635 45.161 19.669
Net Change in Cash -40.327 -39.408 -57.693 -51.343 -34.039
Cash Taxes Paid -0.013 2.237 1.78 0.86 -0.06
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
TPG Capital, L.P. Private Equity 46.371 175284635 0 2023-06-30 LOW
Summit Partners, L.P. Private Equity 12.099 45734703 0 2023-09-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 6.1334 23184620 513142 2023-06-30 LOW
Lester (Michael K.) Individual Investor 5.2891 19993012 -1502956 2022-12-31
Silversmith Capital Partners Private Equity 5.1696 19541192 0 2023-04-14
Qureshi (Danish J.) Individual Investor 2.5901 9790850 -72398 2023-06-21 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.9654 7429385 191892 2023-06-30 LOW
Booth (Gwendolyn H.) Individual Investor 1.7282 6532649 -88798 2022-06-13
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.6825 6359801 1683735 2023-06-30 LOW
Gouk (Warren) Individual Investor 1.5379 5813204 -38058 2023-09-01 LOW
Mullins (Kevin Michael) Individual Investor 1.3009 4917283 -113333 2023-10-02 LOW
Brown Advisory Investment Advisor/Hedge Fund 1.0836 4096093 3226920 2023-09-30 LOW
Principal Global Investors (Equity) Investment Advisor 0.9862 3727796 24796 2023-06-30 LOW
Stockbridge Partners LLC Investment Advisor/Hedge Fund 0.9754 3687152 -3049538 2023-06-30 LOW
Fidelity Institutional Asset Management Investment Advisor 0.856 3235619 88226 2023-06-30 LOW
Bessler (Robert) Individual Investor 0.8102 3062599 21905 2023-07-01 LOW
Rock Springs Capital Management LP Hedge Fund 0.7672 2900000 0 2023-06-30 LOW
Burdick (Kenneth A) Individual Investor 0.6246 2361110 2361110 2023-03-06 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5982 2261394 429132 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.5569 2105143 653041 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

LifeStance Health Company profile

Track the Lifestance Health Group, Inc. stock price today and spot the best opportunities for profitable CFD trades. 

LifeStance is a US company based in Scottsdale, Arizona that was founded in 2017. The business operates outpatient care facilities all over the United States, focusing specifically on mental health services to individuals of all ages. 

LifeStance Health Group made its trading debut on 10 June  2021 in a highly anticipated initial public offering (IPO). The flotation raised $720 million with the company selling 40 million shares at $18 each. The LFST stock price trades under the NASDAQ ticker symbol LFST

LifeStance is also backed by TPG Capital, a private equity firm with around $103 billion in assets. TPG acquired a majority interest in Lifestance Health in March 2020. The IPO valued LifeStance Health Group at over $7 billion.

Successful IPO

LifeStance Health Group IPO seems particularly well-timed, given the  increasing focus on mental health during the COVID-19 global pandemic. LifeStance Health also offers digital telehealth services. 

There is often plenty of initial excitement when IPOs are announced, but equally often that enthusiasm quickly wanes – some companies see their share price fall just days after going public. That doesn’t seem to be the case with LFST. The LifeStance Health Group share price closed up at $21.90 on its first day of trading – that’s an impressive increase of 21.67%. The stock price has since shown a solid base at $20, which is good news for those invested in the IPO.

While the LFST IPO was clearly successful, it’s important to note that the stock could be overvalued. If you are looking for strong profit margins, it’s worth considering that LFST reported a net loss in the first quarter of 2021

Great growth so far

In the first three months of 2021, LifeStance Health made around $143 million in revenue, according to its filings. These also showed that the company made a net loss of $8.7 million over the same period. 

While this number might seem uninspiring for a company valued in the billions, it’s also important to note that this is more revenue than LifeStance Health reported for the whole of 2018. This explosion in growth suggests that the company could have the potential to become a strong player in the mental healthcare sector.

Investment options 

Follow the LFST stock chart in real-time and consider trading it with contracts for difference (CFDs). As always when investing, you should make your own analysis to see if LifeStance Health Group, Inc stock price is an attractive trading opportunity for you.

With CFDs, you can go long or short on the company’s shares and trace all the latest ups and downs of the LifeStance Health Group (LFST) share price using Capital.com’s proprietary CFD trading platform

Industry: Healthcare Facilities & Services (NEC)

4800 N. Scottsdale Road
Suite 6000
SCOTTSDALE
ARIZONA 85251
US

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

Gold

2,035.76 Price
+0.550% 1D Chg, %
Long position overnight fee -0.0185%
Short position overnight fee 0.0103%
Overnight fee time 22:00 (UTC)
Spread 0.50

US100

17,914.30 Price
-0.350% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 7.0

BTC/USD

50,850.15 Price
-1.650% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

XRP/USD

0.54 Price
-2.240% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading